BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32442424)

  • 1. Enhancing the Antiviral Efficacy of RNA-Dependent RNA Polymerase Inhibition by Combination with Modulators of Pyrimidine Metabolism.
    Liu Q; Gupta A; Okesli-Armlovich A; Qiao W; Fischer CR; Smith M; Carette JE; Bassik MC; Khosla C
    Cell Chem Biol; 2020 Jun; 27(6):668-677.e9. PubMed ID: 32442424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
    Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
    Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
    Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
    Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
    J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation.
    Wan YH; Wu WY; Guo SX; He SJ; Tang XD; Wu XY; Nandakumar KS; Zou M; Li L; Chen XG; Liu SW; Yao XG
    Acta Pharmacol Sin; 2020 May; 41(5):706-718. PubMed ID: 31729469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
    Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
    Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights on Dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors.
    Nascimento IJDS; Santos-Júnior PFDS; Aquino TM; Araújo-Júnior JX; Silva-Júnior EFD
    Eur J Med Chem; 2021 Nov; 224():113698. PubMed ID: 34274831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of dihydroorotate dehydrogenase inhibitor, vidofludimus, as a potent and novel inhibitor for influenza virus.
    Li J; Takeda M; Imahatakenaka M; Ikeda M
    J Med Virol; 2024 Jan; 96(1):e29372. PubMed ID: 38235544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification.
    Deans RM; Morgens DW; Ökesli A; Pillay S; Horlbeck MA; Kampmann M; Gilbert LA; Li A; Mateo R; Smith M; Glenn JS; Carette JE; Khosla C; Bassik MC
    Nat Chem Biol; 2016 May; 12(5):361-6. PubMed ID: 27018887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening.
    Okesli-Armlovich A; Gupta A; Jimenez M; Auld D; Liu Q; Bassik MC; Khosla C
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2559-2564. PubMed ID: 31420268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound.
    Madhvi A; Hingane S; Srivastav R; Joshi N; Subramani C; Muthumohan R; Khasa R; Varshney S; Kalia M; Vrati S; Surjit M; Ranjith-Kumar CT
    Sci Rep; 2017 Jul; 7(1):5816. PubMed ID: 28725041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis.
    Yang CF; Gopula B; Liang JJ; Li JK; Chen SY; Lee YL; Chen CS; Lin YL
    Emerg Microbes Infect; 2018 Nov; 7(1):187. PubMed ID: 30459406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
    Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico design of a novel nucleotide antiviral agent by free energy perturbation.
    Patel D; Cox BD; Kasthuri M; Mengshetti S; Bassit L; Verma K; Ollinger-Russell O; Amblard F; Schinazi RF
    Chem Biol Drug Des; 2022 Jun; 99(6):801-815. PubMed ID: 35313085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.
    Li Y; Yi L; Cheng S; Wang Y; Wang J; Sun J; Zhang Q; Xu X
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of dengue virus resistance to brequinar in cell culture.
    Qing M; Zou G; Wang QY; Xu HY; Dong H; Yuan Z; Shi PY
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3686-95. PubMed ID: 20606073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
    Zandi K; Bassit L; Amblard F; Cox BD; Hassandarvish P; Moghaddam E; Yueh A; Libanio Rodrigues GO; Passos I; Costa VV; AbuBakar S; Zhou L; Kohler J; Teixeira MM; Schinazi RF
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Novel
    Sibille G; Luganini A; Sainas S; Boschi D; Lolli ML; Gribaudo G
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
    Murakami E; Niu C; Bao H; Micolochick Steuer HM; Whitaker T; Nachman T; Sofia MA; Wang P; Otto MJ; Furman PA
    Antimicrob Agents Chemother; 2008 Feb; 52(2):458-64. PubMed ID: 17999967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.